Target intelligence / Profile preview

Tumor necrosis factor receptor 1 (TNFR1) (TNFR1)

Target
TNFR1
Molecular classification
Receptor, Tumor necrosis factor receptor superfamily, Single-pass type I membrane protein
01

Overview

Tumor necrosis factor receptor 1 (TNFR1) is a ubiquitous membrane protein that serves as a primary mediator for the biological effects of tumor necrosis factor (TNF). Historically identified in early binding studies as high-affinity cell surface binding sites on various cell lines, including HeLa cells, TNFR1 is characterized by its ability to trigger both pro-inflammatory gene expression and programmed cell death (apoptosis). Upon binding to TNF, the receptor recruits intracellular adapter proteins to its death domain, initiating signaling cascades such as the NF-kappaB and MAPK pathways. In disease states, overactivation of TNFR1 signaling is a hallmark of chronic inflammatory conditions like rheumatoid arthritis and Crohn's disease, making it a critical therapeutic target. Modern biologics, including monoclonal antibodies and soluble receptor decoys, effectively manage these diseases by preventing the interaction between TNF and its high-affinity receptors.

Other names
Tumor necrosis factor receptor superfamily member 1ATNFRSF1ACD120ap55p60TNF-R1High-affinity cell surface binding sites for tumor necrosis factor
02

Mechanism of action

Inhibition of tumor necrosis factor (TNF) binding to its receptors, thereby neutralizing its pro-inflammatory and apoptotic signaling effects.

03

Biological functions

Signal transductionApoptosisInflammationImmune responseCell proliferationCytokine signaling
04

Disease associations

CancerInflammationAutoimmune diseaseRheumatoid arthritisPsoriasisInflammatory bowel disease
05

Safety considerations

Increased risk of serious infections (e.g., tuberculosis)Increased risk of certain malignancies (e.g., lymphoma)Demyelinating disordersCongestive heart failure exacerbation
06

Interacting drugs

Infliximab

4 more in the full profile.

07

Biomarkers

Soluble TNFR1 (sTNFR1) levelsC-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Tumor necrosis factor receptor 1 (TNFR1) (TNFR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor receptor 1 (TNFR1) (TNFR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call